Impact of Poor Sleep on Inflammation and the Adenosine Signaling Pathway in HIV Infection
睡眠不良对 HIV 感染中炎症和腺苷信号通路的影响
基本信息
- 批准号:10155515
- 负责人:
- 金额:$ 49.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdenosineAdverse effectsAnimalsBiochemicalBiologicalBiological FactorsBrain regionCardiopulmonaryCardiovascular DiseasesCardiovascular systemCellsChronicChronic DiseaseChronic lung diseaseComplexControl GroupsCoronary ArteriosclerosisDataDefectDevelopmentDiabetes MellitusDisease MarkerDown-RegulationEndotheliumEpidemiologyFunctional disorderGenerationsHIVHIV InfectionsHealthHeart DiseasesHigh PrevalenceHourHumanImmuneImmunologic MarkersImpairmentIndividualInflammationInflammatoryInterventionLeadLeukocytesLungLung diseasesLung infectionsMeasuresMediatingMorbidity - disease rateNeuraxisObesityOutcomePathway interactionsPatient Self-ReportPeripheralPlayPopulationPremature MortalityProductionPsychological FactorsPulmonary Heart DiseasePurinergic P1 ReceptorsPurinesRegulationResearchRiskRisk FactorsRoleScheduleSignal PathwaySignal TransductionSleepSleep Apnea SyndromesSleep DeprivationSleep disturbancesSocioeconomic FactorsT-Cell ActivationT-LymphocyteTestingUp-RegulationUrineViralWakefulnessWalkingWorkantiretroviral therapybasal forebraincohortcoronary artery calciumendothelial dysfunctionexperienceexperimental studyextracellularimmune activationimmune functionimmunoregulationinflammatory markerinsightnovelnovel therapeutic interventionpoor sleepprematurepreventpulmonary functionreceptor expressionsleep behaviorsleep patternsleep qualitysleep regulationsystemic inflammatory response
项目摘要
ABSTRACT
HIV infection, despite the development and implementation of antiretroviral therapy (ART), is associated with
high levels of inflammation, which appears to be a major factor underlying the elevated risk for premature
cardiovascular and pulmonary disease among people living with HIV. Recent work from our group identifies
impairments in the adenosine signaling pathway as an important mechanism leading to an inability to normally
regulate pro-inflammatory pathways. Adenosine signaling is also a key component to normal sleep-wake
regulation, with extracellular adenosine levels in the basal forebrain and other parts of the central nervous system
serving as the biochemical driver of the homeostatic drive for sleep. Chronically poor sleep, which is highly
prevalent among people living with HIV, has been demonstrated to alter adenosine signaling in the central nervous
system and acute sleep deprivation has been found to alter adenosine receptor expression in leukocytes.
Epidemiologic and experimental data suggest both acute and chronic disruption of normal sleep leads to elevated
inflammation and to many of the same downstream cardiopulmonary health consequences experienced by people
living with HIV. We have found self-reported poor sleep in an HIV(+) population is an independent predictor of
cardiopulmonary disease. In this proposal, we seek to test the hypothesis that one mechanism by which poor sleep
may impact inflammation and cardiopulmonary risk is via effects on peripheral adenosine signaling. We will
assess the association between objectively assessed sleep habits, inflammation and cardiopulmonary disease
markers in an ART-treated HIV(+) population and compare relationships with an HIV(-) control group. In the
setting of HIV infection, we will further compare levels of T-cell immune activation and peripheral adenosine
signaling in those with and without chronic sleep deprivation to assess the impact of chronic sleep habits on
adenosine signaling pathways among people living with HIV. Finally, we will assess the impact of 24 hours of
acute sleep deprivation on adenosine signaling, inflammation, immune activation, and endothelial function in an
HIV(+) population with healthy sleep habits to assess the impact of acute sleep loss on peripheral adenosine
signaling and downstream effects. In total, these experiments will evaluate the role of poor sleep on inflammation
and cardiopulmonary function in people living with HIV and evaluate the extent to which both acute sleep loss
and chronic sleep disruption impact inflammation and immune function in HIV and the role of defects in
peripheral adenosine signaling in mediating these effects. This work will provide insights regarding novel
therapeutic strategies towards preventing the long term cardiovascular and pulmonary complications of HIV
infection.
抽象的
尽管抗逆转录病毒疗法(ART)的发展和实施,HIV感染与
高水平的炎症,这似乎是过早风险升高的主要因素
艾滋病毒患者中的心血管和肺部疾病。我们小组的最新工作确定
腺苷信号通路中的损伤是一种重要机制,导致正常无法
调节促炎途径。腺苷信号传导也是正常睡眠效果的关键组成部分
调节,基础前脑和中枢神经系统其他部位的细胞外腺苷水平
作为稳态驱动器的生化驱动力。长期睡眠不佳,这是高度的
在艾滋病毒感染者中流行,已被证明会改变中枢神经中的腺苷信号传导
已经发现系统和急性睡眠剥夺会改变白细胞中腺苷受体的表达。
流行病学和实验数据表明,正常睡眠的急性和慢性破坏导致升高
炎症以及许多人所经历的许多相同的下游心肺健康后果
与艾滋病毒一起生活。我们发现在艾滋病毒(+)种群中自我报告的睡眠不良是独立的预测指标
心肺疾病。在此提案中,我们试图检验以下假设,即睡眠不佳的一种机制
可能会影响炎症和心肺风险是对外围腺苷信号传导的影响。我们将
评估客观评估的睡眠习惯,炎症和心肺疾病之间的关联
经过艺术处理的艾滋病毒(+)种群中的标记,并将关系与艾滋病毒( - )对照组进行比较。在
艾滋病毒感染的设置,我们将进一步比较T细胞免疫激活和周围腺苷的水平
有或没有慢性睡眠剥夺者的信号传导,以评估慢性睡眠习惯的影响
艾滋病毒患者的腺苷信号通路。最后,我们将评估24小时的影响
腺苷信号传导,炎症,免疫激活和内皮功能的急性睡眠剥夺
具有健康睡眠习惯的HIV(+)人群,以评估急性睡眠损失对周围腺苷的影响
信号传导和下游效果。总的来说,这些实验将评估睡眠不良对炎症的作用
和艾滋病毒患者的心肺功能以及评估急性睡眠丧失的程度
慢性睡眠中断影响艾滋病毒中的炎症和免疫功能以及缺陷在
介导这些作用的周围腺苷信号传导。这项工作将提供有关小说的见解
防止艾滋病毒的长期心血管和肺并发症的治疗策略
感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bernard Jonas C Macatangay其他文献
Bernard Jonas C Macatangay的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bernard Jonas C Macatangay', 18)}}的其他基金
Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure
基于树突状细胞的 HIV 功能性治愈治疗疫苗策略的比较
- 批准号:
9321503 - 财政年份:2017
- 资助金额:
$ 49.59万 - 项目类别:
Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure
基于树突状细胞的 HIV 功能性治愈治疗疫苗策略的比较
- 批准号:
10198701 - 财政年份:2017
- 资助金额:
$ 49.59万 - 项目类别:
Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure
基于树突状细胞的 HIV 功能性治愈治疗疫苗策略的比较
- 批准号:
9973143 - 财政年份:2017
- 资助金额:
$ 49.59万 - 项目类别:
Dipyridamole as a Modulator of HIV-1 Inflammation by Adenosine Regulation
双嘧达莫通过腺苷调节调节 HIV-1 炎症
- 批准号:
9231368 - 财政年份:2014
- 资助金额:
$ 49.59万 - 项目类别:
Dipyridamole as a Modulator of HIV-1 Inflammation by Adenosine Regulation
双嘧达莫通过腺苷调节调节 HIV-1 炎症
- 批准号:
8803308 - 财政年份:2014
- 资助金额:
$ 49.59万 - 项目类别:
Dipyridamole as a Modulator of HIV-1 Inflammation by Adenosine Regulation
双嘧达莫通过腺苷调节调节 HIV-1 炎症
- 批准号:
9020190 - 财政年份:2014
- 资助金额:
$ 49.59万 - 项目类别:
相似国自然基金
基于荧光共振能量转移及指示剂置换法策略纳米组装体比率荧光识别三磷酸腺苷
- 批准号:22361028
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
S-腺苷同型半胱氨酸抑制METTL3调控m6A/miRNA-NCOA4轴致椎间盘退变的机制研究
- 批准号:82372444
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于肝脏腺苷A1受体调控的PKA-SCAP-SREBP1c通路研究知母皂苷AⅢ治疗NAFLD的分子机理
- 批准号:82374129
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
遗传变异调控可变多聚腺苷酸化影响胰腺癌风险的分子流行病学研究
- 批准号:82373663
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
PUF60通过调控SET可变多聚腺苷酸化参与DNA损伤修复促进卵巢癌耐药的机制
- 批准号:82303055
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Merging artificial intelligence (AI) and pharmacometrics to elucidate gene-drug interactions linked to clopidogrel responsiveness in Caribbean Hispanic patients
融合人工智能 (AI) 和药理学,阐明与加勒比西班牙裔患者氯吡格雷反应相关的基因药物相互作用
- 批准号:
10626448 - 财政年份:2023
- 资助金额:
$ 49.59万 - 项目类别:
Therapeutic implications of purinergic receptor P2X4 in ischemic stroke
嘌呤能受体 P2X4 在缺血性中风中的治疗意义
- 批准号:
10634727 - 财政年份:2022
- 资助金额:
$ 49.59万 - 项目类别:
Targeting adenosine monophosphate activated protein kinase (AMPK) to reduce cocaine relapse
靶向单磷酸腺苷激活蛋白激酶 (AMPK) 减少可卡因复吸
- 批准号:
10593045 - 财政年份:2022
- 资助金额:
$ 49.59万 - 项目类别:
Targeting adenosine monophosphate activated protein kinase (AMPK) to reduce cocaine relapse
靶向单磷酸腺苷激活蛋白激酶 (AMPK) 减少可卡因复吸
- 批准号:
10303255 - 财政年份:2022
- 资助金额:
$ 49.59万 - 项目类别:
Adenosinergic Signaling in the Immunoinflammatory Response After Cardiac Arrest
心脏骤停后免疫炎症反应中的腺苷信号传导
- 批准号:
10348682 - 财政年份:2021
- 资助金额:
$ 49.59万 - 项目类别: